Related Experiment Videos
Derangement of growth and differentiation control in oncogenesis
Paul G Corn1, Wafik S El-Deiry
1Department of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Abstract:
Human neoplasms develop following the progressive accumulation of genetic and epigenetic alterations to oncogenes and tumor suppressor genes. These alterations confer a growth advantage to the cancer cell, leading to its clonal proliferation, invasion into surrounding tissues, and spread to distant organs. Genes that are altered in neoplasia affect three major biologic pathways that normally regulate cell growth and tissue homeostasis: the cell cycle, apoptosis, and differentiation. While each of these pathways can be defined by a unique set of molecular events, they are not biologically separate. Rather, they function more as an integrated molecular network, and perturbations in one pathway can have profound consequences on another. Insights into what distinguishes the regulation of growth and differentiation in a normal cell versus a cancer cell have led to the development of novel anticancer therapies.
Insights
Human neoplasms arise from accumulated genetic and epigenetic changes in key genes, disrupting normal cell growth and tissue balance. Understanding these disruptions in cell cycle, apoptosis, and differentiation pathways fuels new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Human neoplasms result from accumulated genetic and epigenetic alterations.
- These alterations affect oncogenes and tumor suppressor genes, conferring a growth advantage.
- Altered genes impact critical pathways regulating cell growth and tissue homeostasis.
Purpose of the Study:
- To elucidate the molecular underpinnings of human neoplasms.
- To understand the interplay between cell cycle, apoptosis, and differentiation pathways in cancer.
- To explore how disruptions in these pathways lead to novel therapeutic strategies.
Main Methods:
- Analysis of genetic and epigenetic alterations in human neoplasms.
- Investigation of key biologic pathways: cell cycle, apoptosis, and differentiation.
- Examination of the integrated molecular network regulating cell growth and homeostasis.
Main Results:
- Neoplasms develop through progressive accumulation of genetic/epigenetic changes.
- Altered genes disrupt cell cycle, apoptosis, and differentiation pathways.
- These pathways function as an integrated network, with cross-consequences.
Conclusions:
- Understanding cancer-specific regulation of growth and differentiation is key.
- Insights into pathway integration drive the development of novel anticancer therapies.
- Targeting these molecular networks offers promising therapeutic avenues.